Journal
TRENDS IN PHARMACOLOGICAL SCIENCES
Volume 39, Issue 4, Pages 402-423Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tips.2018.01.004
Keywords
-
Categories
Funding
- Chemical Biology Lighthouse Initiative University of Copenhagen
Ask authors/readers for more resources
The melanocortin-4 receptor (MC4R) regulates adipose tissue formation and energy homeostasis, and is believed to be a monogenic target for novel antiobesity therapeutics. Several research efforts targeting this receptor have identified potent and selective agonists. While viable agonists have been characterized in vitro, undesirable side effects frequently appeared during clinical trials. The most promising candidates have diverse structures, including linear peptides, cyclic peptides, and small molecules. Herein, we present a compilation of potent MC4R agonists and discuss the pivotal structural differences within those molecules that resulted in good selectivity for MC4R over other melanocortins. We provide insight on recent progress in the field and reflect on directions for development of new agonists.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available